The Developmental Research Projects are an integral component of the Rocky Mountain Regional RCE (RMRCE) strategic plan and research portfolio. A maximum of five developmental projects composed of new and renewal applications will be funded each year for one year with budgets of up to 100K each. These will likely be high risk projects offering potential for the development of novel approaches, reagents, or model systems that will advance biodefense and emerging infectious diseases (EID) research efforts. Developmental Research Projects will also provide critical preliminary data for submission of proposals to diverse funding agencies. These will be used to expand the range and scope of the RMRCE research portfolio, and also to increase the representation of scientists and institutions involved in the RMRCE. The RMRCE will solicit proposals annually from RCE and non-RCE scientists in Region VIII institutions. An RFA will be drafted by the Associate Program Director and approved by the Program Director. The final RFA will then be distributed electronically by the Program Manager to all investigators that have had any involvement in the RMRCE and posted on the RCE Website, as well as to the Vice President for Research Offices of all Region VIII instititions. The latter group will have a unique oversight of all potential RCE participants and programs in their respective institutions and will aid in having the greatest diversity of project proposals submitted. Academic peers, as well as members of the Steering Committee, will review newly proposed Developmental Research Projects. The most promising projects, which are consistent with the strategic plan and program enhancement of the RMRCE and national RCE program, will be selected for funding. Developmental Research Projects previously funded can be resubmitted as a competitive renewal for a second year of funding. If significant new potential for program development is presented after one or two years of funding, the respective Developmental Research Project will be encouraged to submit an application as a full research project to compete for funds made available through the termination of existing but non-productive full research projects. This process will provide maximum flexibility for RMRCE program growth and productivity, and will allow the RMRCE to avail itself of new technologies, talents, and opportunities for program growth, and to address specific needs and goals.

Public Health Relevance

The Developmental Research Projects are an integral part of the RMRCE portfolio as new projects will emerge that provide exciting opportunities for generating new information into fundamental processes that govern the lifestyles and virulence of pathogens, new opportunities to develop therapeutics or vaccines for select agent and priority pathogens, which will potentially benefit the RMRCE and the national biodefense and EID research efforts.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54AI065357-09
Application #
8465794
Study Section
Special Emphasis Panel (ZAI1-DDS-M)
Project Start
Project End
Budget Start
2013-05-01
Budget End
2014-04-30
Support Year
9
Fiscal Year
2013
Total Cost
$514,581
Indirect Cost
$51,623
Name
Colorado State University-Fort Collins
Department
Type
DUNS #
785979618
City
Fort Collins
State
CO
Country
United States
Zip Code
80523
Gibson, Christopher C; Zhu, Weiquan; Davis, Chadwick T et al. (2015) Strategy for identifying repurposed drugs for the treatment of cerebral cavernous malformation. Circulation 131:289-99
Wang, Hong; Siddharthan, Venkatraman; Hall, Jeffery O et al. (2014) Autonomic deficit not the cause of death in West Nile virus neurological disease. Clin Auton Res 24:15-23
Scharton, Dionna; Bailey, Kevin W; Vest, Zachary et al. (2014) Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment. Antiviral Res 104:84-92
Shives, Katherine D; Beatman, Erica L; Chamanian, Mastooreh et al. (2014) West nile virus-induced activation of mammalian target of rapamycin complex 1 supports viral growth and viral protein expression. J Virol 88:9458-71
Calvert, Amanda E; Dixon, Kandice L; Delorey, Mark J et al. (2014) Development of a small animal peripheral challenge model of Japanese encephalitis virus using interferon deficient AG129 mice and the SA14-14-2 vaccine virus strain. Vaccine 32:258-64
Richert, Laura E; Rynda-Apple, Agnieszka; Harmsen, Ann L et al. (2014) CD11cýýý cells primed with unrelated antigens facilitate an accelerated immune response to influenza virus in mice. Eur J Immunol 44:397-408
Soffler, Carl; Bosco-Lauth, Angela M; Aboellail, Tawfik A et al. (2014) Pathogenesis of percutaneous infection of goats with Burkholderia pseudomallei: clinical, pathologic, and immunological responses in chronic melioidosis. Int J Exp Pathol 95:101-19
Porta, Jason; Jose, Joyce; Roehrig, John T et al. (2014) Locking and blocking the viral landscape of an alphavirus with neutralizing antibodies. J Virol 88:9616-23
Jones-Carson, Jessica; Zweifel, Adrienne E; Tapscott, Timothy et al. (2014) Nitric oxide from IFN?-primed macrophages modulates the antimicrobial activity of ?-lactams against the intracellular pathogens Burkholderia pseudomallei and Nontyphoidal Salmonella. PLoS Negl Trop Dis 8:e3079
Phillips, Aaron T; Schountz, Tony; Toth, Ann M et al. (2014) Liposome-antigen-nucleic acid complexes protect mice from lethal challenge with western and eastern equine encephalitis viruses. J Virol 88:1771-80

Showing the most recent 10 out of 181 publications